Page last updated: 2024-11-05

tilorone and Leukemia P388

tilorone has been researched along with Leukemia P388 in 1 studies

Tilorone: An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.
tilorone : A member of the class of fluoren-9-ones that is 9H-fluoren-9-one which is substituted by a 2-(diethylamino)ethoxy group at positions 2 and 7. It is an interferon inducer and a selective alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist. Its hydrochloride salt is used as an antiviral drug.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schulze, W1
Letsch, G1
Gutsche, W1
Wohlrabe, K1
Tresselt, D1

Other Studies

1 other study available for tilorone and Leukemia P388

ArticleYear
[N-quaternary derivatives of tilorone].
    Die Pharmazie, 1984, Volume: 39, Issue:5

    Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Fluorenes; Lethal Dose 50; Leukemia L

1984